Advanced Magnetics targets pancreas:
This article was originally published in Clinica
Diagnostic imaging of the pancreas is the initial aim of an R&D project between Advanced Magnetics and Massachusetts General Hospital. The product development agreement, whereby MGH will receive a minimum payment of $300,000, covers organ-specific, receptor-directed, superparamagnetic iron oxides for use as MRI contrast agents. Initial collaboration will focus on the pancreas - an "extremely difficult" organ to image, says Advanced Magnetics. Cancer of the pancreas affects 40,000 Americans each year.